Suppr超能文献

表达吲哚胺2,3-双加氧酶的T细胞调节性浆细胞样树突状细胞

T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

作者信息

Kahler David J, Mellor Andrew L

机构信息

Department of Medicine, Program in Molecular Immunology, Institute of Molecular Medicine and Genetics, Medical College of Georgia 1120, 15th Street, Augusta, GA 30912-2600, USA.

出版信息

Handb Exp Pharmacol. 2009(188):165-96. doi: 10.1007/978-3-540-71029-5_8.

Abstract

Mature dendritic cells (DCs) are potent stimulators of T cells that recognize antigens presented by the DCs. In this chapter we describe mature DCs that suppress T cell responses to antigens they present due to expression of the intracellular enzyme indoleamine 2,3 dioxygenase (IDO). IDO-competent DCs are a subset of plasmacytoid DCs that can be induced to express IDO under certain inflammatory conditions in humans and mice. Though rare, IDO-expressing DCs acquire potent T cell suppressor activity that may predominate over the T cell stimulatory functions of all other antigen-presenting cells in physiologic environments due in part, to cooperation with regulatory T cells. Thus, IDO-expressing DCs are critical regulators of adaptive immunity that contribute to a wide range of inflammatory disease processes. As such, manipulating IDO expression in DCs using IDO inhibitors or IDO inducers offers considerable opportunities to improve immunotherapies in a range of clinically-significant disease syndromes.

摘要

成熟树突状细胞(DCs)是T细胞的有效刺激物,可识别DCs呈递的抗原。在本章中,我们描述了成熟的DCs,它们由于细胞内酶吲哚胺2,3-双加氧酶(IDO)的表达而抑制T细胞对其呈递抗原的反应。具有IDO活性的DCs是浆细胞样DCs的一个亚群,在人和小鼠的某些炎症条件下可被诱导表达IDO。尽管表达IDO的DCs很少见,但它们获得了强大的T细胞抑制活性,在生理环境中,这种活性可能会超过所有其他抗原呈递细胞的T细胞刺激功能,部分原因是与调节性T细胞的协同作用。因此,表达IDO的DCs是适应性免疫的关键调节因子,参与多种炎症性疾病过程。正因如此,使用IDO抑制剂或IDO诱导剂来调控DCs中的IDO表达,为改善一系列具有临床意义的疾病综合征的免疫疗法提供了相当多的机会。

相似文献

1
T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
Handb Exp Pharmacol. 2009(188):165-96. doi: 10.1007/978-3-540-71029-5_8.
2
Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege.
Int Rev Immunol. 2010 Apr;29(2):133-55. doi: 10.3109/08830180903349669.
6
Physiologic control of IDO competence in splenic dendritic cells.
J Immunol. 2011 Sep 1;187(5):2329-35. doi: 10.4049/jimmunol.1100276. Epub 2011 Aug 3.
8
Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
Transplantation. 2007 Feb 27;83(4):468-73. doi: 10.1097/01.tp.0000251646.09702.ec.
9
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
Blood. 2009 Jul 16;114(3):555-63. doi: 10.1182/blood-2008-11-191197. Epub 2009 May 22.

引用本文的文献

2
Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation.
Int J Mol Sci. 2020 Aug 1;21(15):5515. doi: 10.3390/ijms21155515.
4
Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.
Biomaterials. 2016 Nov;108:168-76. doi: 10.1016/j.biomaterials.2016.09.004. Epub 2016 Sep 6.
6
Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.
Tuberculosis (Edinb). 2014 Dec;94(6):606-15. doi: 10.1016/j.tube.2014.10.001.
7
Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation.
Front Physiol. 2014 Jul 25;5:279. doi: 10.3389/fphys.2014.00279. eCollection 2014.
8
9
Immune heterogeneity in neuroinflammation: dendritic cells in the brain.
J Neuroimmune Pharmacol. 2013 Mar;8(1):145-62. doi: 10.1007/s11481-012-9414-8. Epub 2012 Nov 1.
10
Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.
Kidney Int. 2012 May;81(9):892-902. doi: 10.1038/ki.2011.471. Epub 2012 Feb 8.

本文引用的文献

1
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality.
Blood. 2008 Mar 15;111(6):3257-65. doi: 10.1182/blood-2007-06-096081. Epub 2007 Dec 12.
3
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.
Blood. 2008 Feb 15;111(4):2152-4. doi: 10.1182/blood-2007-10-116111. Epub 2007 Nov 28.
6
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18619-24. doi: 10.1073/pnas.0709261104. Epub 2007 Nov 14.
9
Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.
J Cancer Res Clin Oncol. 2008 May;134(5):525-33. doi: 10.1007/s00432-007-0315-9. Epub 2007 Oct 2.
10
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.
Blood. 2007 Dec 15;110(13):4319-30. doi: 10.1182/blood-2007-02-072587. Epub 2007 Sep 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验